Hair and nail manifestations of COVID‐19. (2nd February 2022)

• Record Type: Journal Article
• Authors: Tammaro, Antonella; Adebanjo, Ganiyat Adenike Ralitsa; Parisella, Francesca Romana; Luzi, Fabiola; Scarabello, Alessandra
• Is Part Of: Journal of cosmetic dermatology. Volume 21:Number 4(2022)
• Page Start: 1339
• Page End: 1346
• Publication Date: 2022-02-02
• Subjects: hair -- hair disease -- hair disorders -- hairloss -- infection -- nail disorders; Skin -- Diseases -- Treatment -- Periodicals; Lasers in surgery -- Periodicals; Skin -- Pathophysiology -- Periodicals; Surgery, Plastic -- Periodicals; 616.5
• DOI: 10.1111/jocd.14774
• Languages: English
• ISSNs: 1473-2130

Abstract

Abstract: Emerging literature evidence shows that the manifestations of the coronavirus disease 2019 (COVID‐19), which is the disease caused by SARS‐CoV‐2, encompass alterations of the pulmonary, cardiovascular, gastrointestinal, and neurological system. Moreover, hematologic and dermatologic manifestations have been documented. The aim of this review is to summarize the dermatologic manifestations of COVID‐19 involving the hair and nails in a narrative way. A total of 1136 patients have been reported to have de novo hair loss following COVID‐19. Notably, 958 patients experienced telogen effluvium (TE) (female/male ratio = 3, 86:1), two female patients experienced anagen effluvium, and 176 people had alopecia areata (female/male ratio of 19:3). Ten patients were reported to have ungual changes following the infection with the novel coronavirus: The individuals affected were 6 women and 4 men. COVID‐19 can be associated with hair and ungual manifestations. This review summarizes the evidence regarding the hair and ungual manifestations of COVID‐19, which could be harnessed to better understand the clinical implications and pathophysiology of this disease that has been burdening society globally since December 2019.